ANOTHER LOOK AT PHYSOSTIGMINE IN ALZHEIMERS-DISEASE

被引:0
|
作者
STERN, Y
SANO, M
MAYEUX, R
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:130 / 130
页数:1
相关论文
共 50 条
  • [1] PHYSOSTIGMINE IN ALZHEIMERS-DISEASE
    SMITH, CM
    SWASH, M
    LANCET, 1979, 1 (8106): : 42 - 42
  • [2] ORAL PHYSOSTIGMINE IN ALZHEIMERS-DISEASE
    DAVIS, KL
    MOHS, RC
    DAVIS, BM
    HORVATH, TB
    GREENWALD, BS
    ROSEN, WG
    LEVY, MI
    JOHNS, CA
    PSYCHOPHARMACOLOGY BULLETIN, 1983, 19 (03) : 451 - 453
  • [3] ORAL PHYSOSTIGMINE IN ALZHEIMERS-DISEASE
    MITCHELL, A
    DRACHMAN, DA
    ODONNELL, B
    GLOSSER, G
    NEUROLOGY, 1986, 36 (04) : 295 - 295
  • [4] PHYSOSTIGMINE IN PATIENTS WITH ALZHEIMERS-DISEASE
    DAVIDSON, M
    MOHS, RC
    HOLLANDER, E
    DAVIS, BM
    RYAN, T
    HORVATH, TB
    DAVIS, KL
    PSYCHOPHARMACOLOGY BULLETIN, 1986, 22 (01) : 101 - 105
  • [5] TRANSDERMAL PHYSOSTIGMINE IN THE TREATMENT OF ALZHEIMERS-DISEASE
    LEVY, A
    BRANDEIS, R
    TREVES, TA
    MESHULAM, Y
    MAWASSI, F
    FEILER, D
    WENGIER, A
    GLIKFELD, P
    GRUNWALD, J
    DACHIR, S
    RABEY, JM
    LEVY, D
    KORCZYN, AD
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1994, 8 (01): : 15 - 21
  • [6] PHYSOSTIGMINE AMELIORATES THE DELUSIONS OF ALZHEIMERS-DISEASE
    CUMMINGS, JL
    GORMAN, DG
    SHAPIRA, J
    BIOLOGICAL PSYCHIATRY, 1993, 33 (07) : 536 - 541
  • [7] EFFECTS OF ORAL PHYSOSTIGMINE IN ALZHEIMERS-DISEASE
    STERN, Y
    SANO, M
    MAYEUX, R
    ANNALS OF NEUROLOGY, 1987, 22 (03) : 306 - 310
  • [8] PHYSOSTIGMINE AND TETRAHYDROAMINOACRIDINE TREATMENT OF ALZHEIMERS-DISEASE
    GUSTAFSON, L
    ACTA NEUROLOGICA SCANDINAVICA, 1993, 88 : 39 - 41
  • [9] MEMORY ENHANCEMENT WITH ORAL PHYSOSTIGMINE IN ALZHEIMERS-DISEASE
    DAVIS, KL
    MOHS, RC
    ROSEN, WG
    GREENWALD, BS
    LEVY, MI
    HORVATH, TB
    NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (12): : 721 - 721
  • [10] CLINICAL PHARMACOKINETICS OF PHYSOSTIGMINE IN PATIENTS WITH ALZHEIMERS-DISEASE
    ASTHANA, S
    GREIG, NH
    HEGEDUS, L
    HOLLOWAY, HH
    RAFFAELE, KC
    SCHAPIRO, MB
    SONCRANT, TT
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 58 (03) : 299 - 309